Abstract A national assessment of the efficacy of pertussis vaccination was made in 21 area health authorities in England. Notification rates for children given either three doses of diphtheria/tetanus/pertussis vaccine or diphtheria/ tetanus vaccine were studied during the two and a half-
Introduction
The efficacy of pertussis vaccination was last assessed nationally in 1966-7.1 I In view of the continuing controversy about the vaccine a fresh assessment was made during the outbreak that began in 1977. This assessment was based on a comparison of the whooping cough notification rates in children under 6 years of age who had received routinely either three doses of diphtheria/ tetanus/pertussis vaccine (DTP) or three doses of diphtheria/ tetanus vaccine (DT). Since these vaccine groups could differ in other ways that might affect attack rates and thus bias this comparison, a separate survey was made of the home circumstances of children given either vaccine.
Procedures
The 21 areas that took part comprised about one-quarter of the total area health authorities in England. The investigation began in January 1978 and continued until June 1980. Children were routinely immunised during the first year of life, the first dose being given at 3-6 months. The vaccination state both of the population under 6 years of age and of the notified cases was provided by each area health authority from their computer records.
Home visits by nurses and health visitors from the AHA were made to notified cases to record the severity of the attack, as judged by the The trial was planned and co-ordinated, and the report prepared at the Epidemiological Research Laboratory, Colindale, by Dr T M Pollock, Dr Elizabeth Miller, Mr J Lobb, and Mrs Gwendoline Smith.
frequency of paroxysms and vomiting, the family circumstances, and to take pernasal swabs. A subsequent home visit about six weeks later was also made to record symptoms in contacts under 6 years. Since infection with Bordetella pertussis is not invariably associated with characteristic symptoms,3 the nurses were asked to report all cases of cough whether or not these were associated with typical paroxysms.
Results

NOTIFICATION RATES IN DTP AND DT VACCINATED CHILDREN
In each of the two vaccine groups roughly 90% of the notifications received were visited. A total of 11 776 cases under 6 years of age, including those discovered at the home visit, had received either three doses of DTP (2261) or three doses of DT (9515).
For each year of birth the attack rate in the DT group was consistently six times greater than in the DTP group; an efficacy of more than 80%* (table I) . Four-weekly notifications of whooping cough. As in the assessment based on the notifications as a whole, the difference in attack rates in home contacts was least in children with no paroxysms and greatest in children with 10 paroxysms or more in whom the estimated efficacy was 71 %.
ISOLATION RATES
The isolation rate for B pertussis in the DTP group was considerably less than in the DT group (table IV) . As a result, when the assessment is restricted to bacteriologically proved cases the efficacy is high-93% for general notifications and 81% for home contacts. Several other characteristics were also examined; these included the number of people in the household, ethnic group, parents' educational attainment, whether or not the mother had a job outside the home, and whether or not the child came from a single parent family, but no material differences were found between the vaccine groups.
Discussion
In this investigation the whooping cough notification rates were found to be much greater in DT vaccinated children than in a similar group of DTP vaccinated children. Notifications are incomplete, and selective under-reporting for one or other of the vaccine groups would affect the estimated efficacy. To account for the findings, however, selective under-reporting on a large scale would have had to occur in the DTP group and to have become progressively more frequent with the increasing severity of the cases; this seems unlikely.
The conclusion that pertussis vaccine is effective is in keeping with most of the assessments in recent years,5 -2 and with the demonstration by Pollard"3 of the direct association between vaccination rates and notification rates in England and Wales. Social factors are sometimes believed to affect assessments of pertussis vaccination, but in Pollard's study the influence of vaccination was apparent even when social factors were taken into account; in the current investigation there was no indication that for the fully vaccinated children in both vaccine groups social class influenced notifications.
Failure to isolate B pertussis does not exclude a diagnosis of whooping cough, and the difficulties of isolation are sometimes greater when whooping cough occurs in those vaccinated. 6 14-16 In assessing the efficacy of the vaccine therefore it is not possible to rely on bacteriologically proved cases alone. Furthermore, the identification of B pertussis in cases without paroxysmal coughalso reported elsewhere' 3'"-necessitates the inclusion in the assessment of cases both with and without paroxysms.
The criteria adopted for the diagnosis of whooping cough considerably affects the degree of efficacy attributed to pertussis vaccine. Thus in the present assessment bacteriologically proved whooping cough was about 14 times more frequent in DT than in DTP vaccinated children, an efficacy of about 93%. This degree of efficacy is much the same as estimated by Preston7 for bacteriologically proved cases. A similar degree of efficacy was also apparent for children sufficiently ill to require hospital admission. Overall the vaccine is highly effective in reducing dissemination, and in protecting the individual against typical whooping cough. But efficacy was much less when the assessment was confined to attacks without typical paroxysms. Such mild attacks might be expected to include a relatively large proportion of cases due to agents other than B pertussis, whose inclusion in both vaccine groups would reduce the estimated efficacy. On the other hand, the decreased efficacy in mild cases may reflect the capacity ofthe vaccine to attenuate attacks.3 610 14 18 Mild attacks-whatever their origin-in DTP vaccinated children may be of little importance to the individual affected but B pertussis can sometimes be isolated from these patients, and they are therefore a potential risk to contacts.
In the stringent conditions of home exposure protection was less than that exhibited by the notifications as a whole. A low degree of efficacy was also observed in home contacts given vaccine of adequate potency in the previous PHLS study, ' and again in a recent investigation in Swansea. 6 The results of this assessment, therefore, while confirming the outstanding benefits conferred by vaccination in preventing and modifying attacks and in reducing infectivity, illustrate also the limitations of the current vaccines in controlling whooping cough. Firstly, complete protection is not invariable and severe attacks can occur in vaccinated children. Secondly, for one important group, home contacts, the degree of protection falls short of that expected from most vaccines in current use.
Thirdly, mild attacks, in vaccinated children, may contribute to the spread of the disease. Given these limitations and the fact that for some years before 1968 some of the vaccines used were of low potency,' it is not surprising that widespread pertussis immunisation-even the high rates pertaining before 1974-did not eradicate the disease in England.
Nevertheless, high vaccination rates were gradually bringing whooping cough under control. But there is little room for complacency. A return to these rates and the development of more effective vaccines based on identifiable protective antigens are urgently required.
